Sanofi is a French multinational healthcare and biopharmaceutical company, one of the largest pharmaceutical groups in the world. Created in 1973 and reshaped by the 1999 Sanofi-Synthelabo merger and the 2004 acquisition of Aventis, it develops and commercializes prescription medicines and vaccines with a focus on immunology, neurology, oncology, rare diseases and rare blood disorders. Its flagship products include Dupixent and Beyfortus alongside a broad influenza and pediatric vaccine portfolio. Headquartered at 'La Maison Sanofi' in Paris, the group employs roughly 85,000 people across some 90 countries and is listed on Euronext Paris (SAN) with ADSs on Nasdaq (SNY).